BioCentury
ARTICLE | Company News

Ember Therapeutics, Mariel deal

March 23, 2015 7:00 AM UTC

Obesity and diabetes company Ember and Mariel, which is developing compounds targeting bone morphogenetic protein 7 ( BMP7; OP-1), will merge and form Ember Therapeutics Inc. The companies did not di...